Trial intelligence / Profile preview

Ropivacaine versus lidocaine local anesthesia for pain after tonsillectomy

2025-520820-44-00Phase 4Authorised

Sponsor
Tauernklinikum
Start
Jun 2025
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4 trial of ropivacaine and lidocaine in chronic tonsillitis (2 arms), sponsored by Tauernklinikum. Primary endpoint: Average postoperative pain score within first 72 hours. Planned start Jun 2025; status: authorised.

02

Drugs

ropivacainelidocaine
03

Conditions

chronic tonsillitis

Beyond the preview

Go deeper on 2025-520820-44-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2025-520820-44-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call